| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.7B | $7.2B | $7.8B | $7.8B | $5.2B | $2.2B | $2.2B | $2.3B |
| Cost of Revenue | $4.1B | $4.3B | $4.8B | $4.7B | $3.5B | $3.9B | $4.0B | — |
| Gross Profit | $2.6B | $2.8B | $3.1B | $3.1B | $1.7B | $0.9B | $0.9B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.1B | $2.2B | $2.2B | $2.2B | $1.6B | $1.9B | $2.0B | $1.9B |
| Operating Income | $0.1B | $0.6B | $0.6B | $0.9B | $-0.1B | $0.2B | $-0.8B | $0.6B |
| Net Income | $0.1B | $0.8B | $0.4B | $0.8B | $-0.0B | $0.2B | $-0.1B | $0.3B |
| EPS (Basic) | $-0.81 | $17.28 | $7.34 | $14.01 | $-0.94 | $3.45 | $-2.25 | $5.70 |
| EPS (Diluted) | $-0.81 | $15.01 | $6.64 | $12.22 | $-0.94 | $3.14 | $-2.25 | $5.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B | $6.8B | $6.6B | $6.6B | $6.2B | $6.3B | $4.4B | $5.8B |
| Current Assets | $2.7B | $3.5B | $3.5B | $3.7B | $3.6B | $3.2B | $2.9B | $3.4B |
| Cash & Equivalents | $0.6B | $1.4B | $1.2B | $1.4B | $1.2B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $3.9B | $4.0B | $4.4B | $4.4B | $4.3B | $4.5B | $2.6B | $2.7B |
| Current Liabilities | $1.8B | $2.0B | $2.2B | $2.1B | $2.0B | $1.7B | $1.0B | $1.0B |
| Stockholders' Equity | $1.9B | $2.2B | $1.6B | $1.6B | $1.2B | $1.2B | $1.2B | $2.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.8B | $1.3B | $1.4B | $0.6B | $0.7B | $1.9B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.5B | $-0.6B | $-0.1B | $-0.1B | $-0.1B | $-0.6B |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $-1.2B | $-0.3B | $-0.5B | $-0.4B | $-0.5B | $-0.2B | $-0.6B | $-1.3B |